Learn from the MHRA about evolving CMC expectations, submission criteria, and initiatives for streamlining approval routes for mRNA platforms. Continuous processing: Optimizing efficiency & ...
A new mRNA platform targets tumors with precision, limits side effects, and converts immune-silent cancers into responsive ...
STONY BROOK, NY / ACCESSWIRE / September 17, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced its participation at upcoming mRNA ...
LineaRx will present its Linea™ IVT platform - a combination of an enzymatically produced DNA template (Linea™ DNA IVT template) coupled with a next-generation RNA polymerase (Linea™ RNAP) - as a ...
4don MSN
Customizable nanomedicine platform shows promise for advancing personalized mRNA cancer therapeutics
Messenger RNA (mRNA) therapeutics hold significant promise for the future of personalized cancer treatment, but persistent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback